Skip to content
RDL Network logo
Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients — Francesca Fumagalli (2020) | RDL Network